成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Journal of Cosmetic and Laser Therapy >>article
Journal of Cosmetic and Laser Therapy

Journal of Cosmetic and Laser Therapy

IF: 1.2
Download PDF

Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate.

Published:1 January 2019 DOI: 10.1080/14764172.2018.1525745 PMID: 30285513
Yegyu Sung, Min Hee Kim, Eujin Cho

Abstract

Dermal fillers are highly favored around the globe as minimally invasive or nonsurgical procedures. Imatinib mesylate is the first-line treatment for patients diagnosed with chronic myeloid leukemia. However, some studies describe that imatinib mesylate may increase the tendency of skin fragility which can lead to easy bruising and hyperpigmentation after invasive skin procedures. Yet, to our knowledge, no studies have described any successful dermal filler injection performed on patients who are under imatinib mesylate treatment. Hence, we present a case successfully treated with hyaluronic acid filler injection on a patient under imatinib mesylate treatment. We carefully propose that hyaluronic acid filler can be an effective means of rejuvenation and cosmetic enhancement for those under imatinib mesylate treatment.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Imatinib mesylate 220127-57-1 C30H35N7O4S 772 suppliers $5.00-$1600.00
Hyaluronic acid 9004-61-9 C14H22NNaO11 612 suppliers $60.00-$1174.00

Similar articles

IF:1.5

Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.

Journal of Drugs in Dermatology Noah Scheinfeld,etc Published: 1 March 2006
IF:0

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin.

Cureus Wasey Ali Yadullahi Mir, Dhan B Shrestha,etc Published: 6 August 2021
IF:0

Liposomal Eribulin Mesylate

Definitions Published: 2 February 2020